| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 6.53e-05 | 303 | 46 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 2.78e-04 | 562 | 46 | 7 | GO:0003712 | |
| GeneOntologyCellularComponent | side of membrane | 1.03e-04 | 875 | 46 | 9 | GO:0098552 | |
| GeneOntologyCellularComponent | canonical inflammasome complex | 7.09e-04 | 18 | 46 | 2 | GO:0061702 | |
| GeneOntologyCellularComponent | cytoplasmic side of plasma membrane | 7.25e-04 | 185 | 46 | 4 | GO:0009898 | |
| Domain | PAS | 1.57e-03 | 25 | 44 | 2 | PF00989 | |
| Domain | PAS_fold | 1.57e-03 | 25 | 44 | 2 | IPR013767 | |
| Domain | PAC | 1.70e-03 | 26 | 44 | 2 | IPR001610 | |
| Domain | PAC | 1.70e-03 | 26 | 44 | 2 | SM00086 | |
| Domain | PAS | 2.57e-03 | 32 | 44 | 2 | SM00091 | |
| Domain | PAS | 2.90e-03 | 34 | 44 | 2 | IPR000014 | |
| Domain | GPS | 2.90e-03 | 34 | 44 | 2 | SM00303 | |
| Domain | PAS | 2.90e-03 | 34 | 44 | 2 | PS50112 | |
| Domain | GPS | 3.07e-03 | 35 | 44 | 2 | PF01825 | |
| Domain | GPS | 3.25e-03 | 36 | 44 | 2 | PS50221 | |
| Domain | GPS | 3.43e-03 | 37 | 44 | 2 | IPR000203 | |
| Domain | VWA | 7.71e-03 | 56 | 44 | 2 | PF00092 | |
| Pubmed | SHAP potentiates the CD44-mediated leukocyte adhesion to the hyaluronan substratum. | 1.79e-06 | 2 | 47 | 2 | 16702221 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 28813675 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 17975002 | ||
| Pubmed | RIPK3 collaborates with GSDMD to drive tissue injury in lethal polymicrobial sepsis. | 1.79e-06 | 2 | 47 | 2 | 32152555 | |
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 32604168 | ||
| Pubmed | 1.79e-06 | 2 | 47 | 2 | 34548542 | ||
| Pubmed | Receptors for hyaluronic acid and poliovirus: a combinatorial role in glioma invasion? | 1.79e-06 | 2 | 47 | 2 | 22363471 | |
| Pubmed | Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma. | 5.36e-06 | 3 | 47 | 2 | 12893366 | |
| Pubmed | Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. | 5.36e-06 | 3 | 47 | 2 | 16998483 | |
| Pubmed | RIP3 antagonizes a TSC2-mediated pro-survival pathway in glioblastoma cell death. | 5.36e-06 | 3 | 47 | 2 | 27984090 | |
| Pubmed | 1.78e-05 | 5 | 47 | 2 | 37998361 | ||
| Pubmed | The NADPH oxidase subunit p22phox inhibits the function of the tumor suppressor protein tuberin. | 1.78e-05 | 5 | 47 | 2 | 20304964 | |
| Pubmed | Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. | 1.78e-05 | 5 | 47 | 2 | 26375003 | |
| Pubmed | Pathogen blockade of TAK1 triggers caspase-8-dependent cleavage of gasdermin D and cell death. | 1.78e-05 | 5 | 47 | 2 | 30361383 | |
| Pubmed | Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. | 1.78e-05 | 5 | 47 | 2 | 26611636 | |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 19110483 | ||
| Pubmed | Gasdermin E permits interleukin-1 beta release in distinct sublytic and pyroptotic phases. | 2.67e-05 | 6 | 47 | 2 | 33852854 | |
| Pubmed | 2.67e-05 | 6 | 47 | 2 | 33109609 | ||
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 38000038 | ||
| Pubmed | 3.74e-05 | 7 | 47 | 2 | 31251782 | ||
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 34648590 | ||
| Pubmed | cFLIPL protects macrophages from LPS-induced pyroptosis via inhibition of complex II formation. | 4.98e-05 | 8 | 47 | 2 | 32193329 | |
| Pubmed | 4.98e-05 | 8 | 47 | 2 | 28410991 | ||
| Pubmed | A Two-Cell Model for IL-1β Release Mediated by Death-Receptor Signaling. | 6.40e-05 | 9 | 47 | 2 | 32268091 | |
| Pubmed | An Apoptotic Caspase Network Safeguards Cell Death Induction in Pyroptotic Macrophages. | 6.40e-05 | 9 | 47 | 2 | 32726624 | |
| Pubmed | 6.43e-05 | 57 | 47 | 3 | 18022353 | ||
| Pubmed | A transcriptional inhibitor targeted by the atypical orphan nuclear receptor SHP. | 7.99e-05 | 10 | 47 | 2 | 11964378 | |
| Pubmed | BAX/BAK-Induced Apoptosis Results in Caspase-8-Dependent IL-1β Maturation in Macrophages. | 7.99e-05 | 10 | 47 | 2 | 30485805 | |
| Pubmed | Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense. | 9.75e-05 | 11 | 47 | 2 | 32298652 | |
| Pubmed | 9.75e-05 | 11 | 47 | 2 | 16109736 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.06e-04 | 1105 | 47 | 8 | 35748872 | |
| Pubmed | 1.17e-04 | 12 | 47 | 2 | 30451870 | ||
| Pubmed | ZBP1 promotes LPS-induced cell death and IL-1β release via RHIM-mediated interactions with RIPK1. | 1.38e-04 | 13 | 47 | 2 | 33397971 | |
| Pubmed | 1.38e-04 | 13 | 47 | 2 | 32763970 | ||
| Pubmed | Activity of caspase-8 determines plasticity between cell death pathways. | 1.61e-04 | 14 | 47 | 2 | 31723262 | |
| Pubmed | 1.61e-04 | 14 | 47 | 2 | 12482968 | ||
| Pubmed | T cells instruct myeloid cells to produce inflammasome-independent IL-1β and cause autoimmunity. | 1.61e-04 | 14 | 47 | 2 | 31848486 | |
| Pubmed | 1.86e-04 | 15 | 47 | 2 | 35907431 | ||
| Pubmed | 1.86e-04 | 15 | 47 | 2 | 31494268 | ||
| Pubmed | 1.86e-04 | 15 | 47 | 2 | 30485804 | ||
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 2.70e-04 | 18 | 47 | 2 | 18834073 | |
| Pubmed | A unique death pathway keeps RIPK1 D325A mutant mice in check at embryonic day 10.5. | 2.70e-04 | 18 | 47 | 2 | 34437534 | |
| Pubmed | 2.70e-04 | 18 | 47 | 2 | 23211419 | ||
| Pubmed | 3.69e-04 | 21 | 47 | 2 | 19596656 | ||
| Pubmed | 4.05e-04 | 257 | 47 | 4 | 16335952 | ||
| Pubmed | Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. | 4.06e-04 | 22 | 47 | 2 | 9324354 | |
| Pubmed | 5.26e-04 | 25 | 47 | 2 | 35139355 | ||
| Pubmed | Induction of Gastric Cancer by Successive Oncogenic Activation in the Corpus. | 5.26e-04 | 25 | 47 | 2 | 34391772 | |
| Pubmed | 5.26e-04 | 25 | 47 | 2 | 27917412 | ||
| Pubmed | 7.09e-04 | 29 | 47 | 2 | 33278357 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 7.85e-04 | 1489 | 47 | 8 | 28611215 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 8.46e-04 | 313 | 47 | 4 | 38270169 | |
| Pubmed | 9.19e-04 | 33 | 47 | 2 | 32140074 | ||
| Pubmed | Joint influence of small-effect genetic variants on human longevity. | 9.75e-04 | 34 | 47 | 2 | 20834067 | |
| Pubmed | 1.15e-03 | 152 | 47 | 3 | 38360978 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.16e-03 | 588 | 47 | 5 | 38580884 | |
| Pubmed | 1.35e-03 | 40 | 47 | 2 | 34677125 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 5.91e-04 | 159 | 47 | 3 | chr7q36 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 4.86e-04 | 17 | 35 | 2 | 486 | |
| GeneFamily | CD molecules|Mucins | 7.47e-04 | 21 | 35 | 2 | 648 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 2.32e-03 | 37 | 35 | 2 | 454 | |
| GeneFamily | Immunoglobulin like domain containing | 6.10e-03 | 193 | 35 | 3 | 594 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 6.82e-03 | 394 | 35 | 4 | 471 | |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN | 1.47e-06 | 199 | 47 | 6 | M5201 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.97e-07 | 167 | 47 | 5 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.97e-07 | 167 | 47 | 5 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.36e-06 | 109 | 47 | 4 | a84a4a3ac19692e5595b9820d49e12ae336f4bbf | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.36e-06 | 109 | 47 | 4 | f7d7b67f7585f2ae0ac905bcf3980264cf9234b8 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.36e-06 | 109 | 47 | 4 | f007fa3dc92d6c8543585e47ccec218263b3266e | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.36e-06 | 109 | 47 | 4 | f4b9fe5335cabe48a5fae7ec51bab0d7bdb17321 | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Striatum / BrainAtlas - Mouse McCarroll V32 | 5.36e-06 | 109 | 47 | 4 | 8460683529759585bd363d10a16ee13af2bd4e28 | |
| ToppCell | facs-Aorta-Heart-24m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-05 | 146 | 47 | 4 | d8d24851e8d8d90795a6f9378418f209200d55b1 | |
| ToppCell | droplet-Kidney-nan-18m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 157 | 47 | 4 | eb64a4e89843895d16015c7d51805f164ed7ea5b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-05 | 165 | 47 | 4 | 6a621b300442c52adfc15b61d3a6d3a3cb00099f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 168 | 47 | 4 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 171 | 47 | 4 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 181 | 47 | 4 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.95e-05 | 181 | 47 | 4 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.30e-05 | 185 | 47 | 4 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.30e-05 | 185 | 47 | 4 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.48e-05 | 187 | 47 | 4 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.48e-05 | 187 | 47 | 4 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.67e-05 | 189 | 47 | 4 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.67e-05 | 189 | 47 | 4 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.77e-05 | 190 | 47 | 4 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | pdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.77e-05 | 190 | 47 | 4 | b05db0de9b6ae01dd30074453f7de44f7397631e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.77e-05 | 190 | 47 | 4 | 951e067d14412db67dc3babcdf61e41717d7b429 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.77e-05 | 190 | 47 | 4 | 2655df8c0883dd811fa7617301f9c4b0a4dd55ec | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.77e-05 | 190 | 47 | 4 | 84fbd5664ec886120963d4f50dfa1fd1851d36c1 | |
| ToppCell | Control-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 5.07e-05 | 193 | 47 | 4 | 2a6d531abd34df20941cf3dac4fdfb1621a1bde6 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.27e-05 | 195 | 47 | 4 | 4a5d2f62aad5817d077177bf8b4ff0e46d3b8d97 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.27e-05 | 195 | 47 | 4 | 7a32a8535c29b819dacba901d0658280a2631c94 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.71e-05 | 199 | 47 | 4 | 6723287924750a2247a07ab6e561066a97b09771 | |
| ToppCell | IPF-Myeloid-Macrophage|Myeloid / Disease state, Lineage and Cell class | 5.71e-05 | 199 | 47 | 4 | 3c2b362d5e824e1a04830e70352f8818de984174 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 5.82e-05 | 200 | 47 | 4 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | 10x_3'_v2v3-Neoplastic|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.82e-05 | 200 | 47 | 4 | e9c7d7cb5fa63fc92aa91d02ae8bd05438d465bc | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.26e-04 | 92 | 47 | 3 | bbaf5a131f860198840e34843b7c841bcc98d9c4 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn_(Dcn)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.26e-04 | 92 | 47 | 3 | e6aa2b8ca9235a7291ee41d976b886fec185835d | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)--|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.34e-04 | 94 | 47 | 3 | c73e99890431750b74f984de5c82e33533ab708b | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.34e-04 | 94 | 47 | 3 | 1bda61101f45f5c4a68453087b880fdc6d9acfca | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Th.Nr4a2_(Neuron.Gad1Gad2-Th.Nr4a2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.34e-04 | 94 | 47 | 3 | 9664f74bc0168c92fb8a68cad628323c476f6103 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Papillary_Carcinoma-8|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.71e-04 | 102 | 47 | 3 | 631b22bd588e5259873b4253435a6e6b3cced346 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 104 | 47 | 3 | a4ae3cae44aac8b6e0d14896f9acab44f0cc97c4 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-04 | 128 | 47 | 3 | 082b3dc312b033c9b21cf73499009a1dc049ee2b | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tfh|Lung / Manually curated celltypes from each tissue | 3.81e-04 | 134 | 47 | 3 | da3cb572d0c19932619e51e272c0555e91b482ac | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.09e-04 | 148 | 47 | 3 | 31a7c2b20970070b14d2b955020320a6f99db547 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.09e-04 | 148 | 47 | 3 | 3f48f5ba0a0928ddf6da7a1be1976933921f42ad | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_C|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.52e-04 | 33 | 47 | 2 | 5ce59ecc7f8432b14dc6cb9af56e1bf080e7d61f | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-capillary_endothelial_Hpgd-CA4_high|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.71e-04 | 154 | 47 | 3 | 212c340a096a3a9669d1aebd61c045cf1402a868 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.04e-04 | 157 | 47 | 3 | f2bc60ec0305b056d79f1b7fd6b5e3730d606916 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.04e-04 | 157 | 47 | 3 | 552fd5d09bbe81f58404ec38166feb30fc84def5 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 6.27e-04 | 159 | 47 | 3 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | Severe-B_naive-11|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.50e-04 | 161 | 47 | 3 | ad3b58e3a8b59a609c8d2d2690d15218d18eabbd | |
| ToppCell | Myeloid|World / shred on cell class and cell subclass (v4) | 6.50e-04 | 161 | 47 | 3 | aee407d3739dba2d5216dcdb1579e7e4f483123d | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-04 | 162 | 47 | 3 | 3fd6aaf0fbaffc7ab38aa25e46c37ef511e1e704 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-04 | 162 | 47 | 3 | 8134f73eb76693f4f1845f643042fdc1e81c274c | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-04 | 162 | 47 | 3 | 08ee7ae56e4927874515c47adc86dd845bf29a26 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.85e-04 | 164 | 47 | 3 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.85e-04 | 164 | 47 | 3 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.85e-04 | 164 | 47 | 3 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.85e-04 | 164 | 47 | 3 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.85e-04 | 164 | 47 | 3 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-04 | 165 | 47 | 3 | 1d844d19ff9b49dd0f61f0b24799e172076771ef | |
| ToppCell | PND14-Immune-Immune_Myeloid|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-04 | 165 | 47 | 3 | e37d00084f58fbd25f66ee65be510c030167084e | |
| ToppCell | facs-Lung-nan-3m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-04 | 165 | 47 | 3 | 720649f330382ea2a68c64a5344160a048afb8f1 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-04 | 165 | 47 | 3 | 9a6abd0e6b11860231ce5e845c87b8d66f3ef697 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-04 | 165 | 47 | 3 | 4fe7c3c9370a556cf4e308a2e723b4b907a6cc25 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.98e-04 | 165 | 47 | 3 | 433771abefc5bcb89bdae64af45cce7407bffe5d | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.10e-04 | 166 | 47 | 3 | 73b472ea846968a08b2ac09269fca5b333ecdf2d | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-04 | 166 | 47 | 3 | 82fa07632f7e586698fbf37381715b40f9f6ae3a | |
| ToppCell | PND01-03-samps-Myeloid|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 7.10e-04 | 166 | 47 | 3 | 99dc8a186ec12d3563e81fa4618a814740332c73 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-04 | 166 | 47 | 3 | b7f303203068b205f382788815df487a0ea148ed | |
| ToppCell | PND28-Immune-Immune_Myeloid|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.10e-04 | 166 | 47 | 3 | caa992944bc7488a6868dbd1902bc3ead6945eb1 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-04 | 166 | 47 | 3 | 0d03926452414f232c77fd15d5f48d148f9fca3b | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.22e-04 | 167 | 47 | 3 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.22e-04 | 167 | 47 | 3 | cf6206c506715cd846799c62cf7c06e3fa99f7af | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.22e-04 | 167 | 47 | 3 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.35e-04 | 168 | 47 | 3 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.35e-04 | 168 | 47 | 3 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | PND03-Immune-Immune_Myeloid|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.35e-04 | 168 | 47 | 3 | f7b911ed2d9d38bab6609da3c37e157ccf1c867b | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 169 | 47 | 3 | 2d3618f78484bd3508b7bdae3a0d0183cdae5057 | |
| ToppCell | droplet-Heart-4Chambers-18m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 169 | 47 | 3 | ea43002e74076aa03bf688c0a76c07117787d4b5 | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 169 | 47 | 3 | 4ac21e8199de4b6917eacadc56fffc6d886ee643 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 169 | 47 | 3 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.48e-04 | 169 | 47 | 3 | 907e4c7d0df6dd46664d69834251aebca8e1dd1e | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.61e-04 | 170 | 47 | 3 | f08aa6168ff0c20b2083dbf588dd3294e3d9580e | |
| ToppCell | Monocytes-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 7.61e-04 | 170 | 47 | 3 | 4e93b66b3033e6e4d5f6d2f41974623a53108f5e | |
| ToppCell | Severe-B_naive-11|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.74e-04 | 171 | 47 | 3 | 7c2699f19ca38414447a286f7658f507882d57c2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.74e-04 | 171 | 47 | 3 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | PND07-Immune-Immune_Myeloid|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.74e-04 | 171 | 47 | 3 | f68cbfa2eb1f39401a31dbd9b630023249406098 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_IT-L6_IT_VISp_Penk_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.74e-04 | 171 | 47 | 3 | d07e2c5f7d7f12c68860d4161d76372de174f1d8 | |
| ToppCell | droplet-Heart-4Chambers-18m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-04 | 171 | 47 | 3 | 4935a95d11ac997d183fab32cbaad837bf0a512b | |
| ToppCell | droplet-Liver-Npc-18m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-04 | 171 | 47 | 3 | e9c42ce444d42cbb4f97e81393756531bfe61637 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-04 | 172 | 47 | 3 | 574ebdf36e45222bcd907cd2c2ee7ff50ed4573a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-04 | 172 | 47 | 3 | 72fbfa890995e47048b47199c170cc7dcd7661f8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-04 | 172 | 47 | 3 | 2ca6f0d1181aabe0d0e3e8f2e193f08dbda42dea | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.87e-04 | 172 | 47 | 3 | 6f302ed795767a9636081dc64373f8f039ea16d2 | |
| ToppCell | facs-BAT-Fat-18m-Myeloid|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-04 | 172 | 47 | 3 | 8e91831804a120037c71cd4e74af686f3c32d31c | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.87e-04 | 172 | 47 | 3 | e72966ced5f2ee9e24ce9fd820d99a69a482a607 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-04 | 172 | 47 | 3 | 0457ccc18697aaec44b7c30ae157aae8f48d8785 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.87e-04 | 172 | 47 | 3 | fd8097299fc05390b30afaa9e6c80b1f607c27aa | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-04 | 172 | 47 | 3 | 94093d356b0252b440deda4e1b0ac332b31513f6 | |
| ToppCell | facs-BAT-Fat-18m-Myeloid-myeloid_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-04 | 172 | 47 | 3 | ea4da9aab7a2ff854df21da01d11c9ed99e41fb4 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.87e-04 | 172 | 47 | 3 | f557ec1b4d08b42559da02dd1f2387283c6380a2 | |
| Drug | Chlorambucil [305-03-3]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 1.22e-07 | 195 | 46 | 7 | 4345_DN | |
| Drug | 3-aminobenzamide; Up 200; 10000uM; MCF7; HG-U133A | 1.27e-07 | 196 | 46 | 7 | 590_UP | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.31e-07 | 197 | 46 | 7 | 3209_UP | |
| Drug | Sulconazole nitrate [61318-91-0]; Up 200; 8.6uM; PC3; HT_HG-U133A | 1.36e-07 | 198 | 46 | 7 | 6652_UP | |
| Drug | N6,2'-O-Dibutyryladenosine 3',5'-cyclic monophosphate sodium salt; Up 200; 20uM; MCF7; HG-U133A | 1.45e-07 | 200 | 46 | 7 | 591_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; HL60; HT_HG-U133A | 2.50e-06 | 194 | 46 | 6 | 3015_DN | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A | 2.73e-06 | 197 | 46 | 6 | 6100_DN | |
| Drug | Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; HL60; HT_HG-U133A | 2.89e-06 | 199 | 46 | 6 | 3017_DN | |
| Drug | guanidinoacetate | 3.68e-06 | 52 | 46 | 4 | CID000000763 | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; HL60; HT_HG-U133A | 4.19e-05 | 192 | 46 | 5 | 2919_DN | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; HL60; HT_HG-U133A | 4.40e-05 | 194 | 46 | 5 | 2485_DN | |
| Drug | Hexestrol [84-16-2]; Down 200; 14.8uM; HL60; HT_HG-U133A | 4.40e-05 | 194 | 46 | 5 | 2515_DN | |
| Drug | Ungerine nitrate; Down 200; 10.2uM; MCF7; HT_HG-U133A | 4.40e-05 | 194 | 46 | 5 | 6076_DN | |
| Drug | Nabumetone [42924-53-8]; Down 200; 17.6uM; HL60; HT_HG-U133A | 4.51e-05 | 195 | 46 | 5 | 3108_DN | |
| Drug | Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; HL60; HT_HG-U133A | 4.51e-05 | 195 | 46 | 5 | 3110_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 4.51e-05 | 195 | 46 | 5 | 6845_DN | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HG-U133A | 4.62e-05 | 196 | 46 | 5 | 384_UP | |
| Drug | Allantoin [97-59-6]; Down 200; 25.2uM; PC3; HT_HG-U133A | 4.62e-05 | 196 | 46 | 5 | 5052_DN | |
| Drug | probucol; Up 200; 10uM; MCF7; HG-U133A | 4.62e-05 | 196 | 46 | 5 | 592_UP | |
| Drug | Monocrotaline [315-22-0]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 2749_UP | |
| Drug | Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 3411_UP | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 2324_DN | |
| Drug | Diltiazem hydrochloride [33286-22-5]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 1532_UP | |
| Drug | Furazolidone [67-45-8]; Down 200; 17.8uM; HL60; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 3019_DN | |
| Drug | Vinpocetine [42971-09-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 7213_DN | |
| Drug | Piperine [94-62-2]; Up 200; 14uM; HL60; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 1327_UP | |
| Drug | 2-Chloropyrazine [14508-49-7]; Up 200; 35uM; PC3; HT_HG-U133A | 4.74e-05 | 197 | 46 | 5 | 5750_UP | |
| Drug | Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 5837_UP | |
| Drug | genistein; Down 200; 10uM; HL60; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 6194_DN | |
| Drug | paclitaxel; Up 200; 0.1uM; MCF7; HG-U133A | 4.85e-05 | 198 | 46 | 5 | 640_UP | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 6460_UP | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; HL60; HT_HG-U133A | 4.97e-05 | 199 | 46 | 5 | 2563_UP | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; MCF7; HT_HG-U133A | 4.97e-05 | 199 | 46 | 5 | 6492_UP | |
| Drug | Albendazole [54965-21-8]; Up 200; 15uM; MCF7; HT_HG-U133A | 4.97e-05 | 199 | 46 | 5 | 3164_UP | |
| Drug | Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; HL60; HG-U133A | 4.97e-05 | 199 | 46 | 5 | 1725_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; HL60; HT_HG-U133A | 5.09e-05 | 200 | 46 | 5 | 2348_UP | |
| Drug | Diazoxide [364-98-7]; Up 200; 17.4uM; HL60; HG-U133A | 5.09e-05 | 200 | 46 | 5 | 1368_UP | |
| Drug | aprosulate | 1.11e-04 | 8 | 46 | 2 | CID000072125 | |
| Drug | famciclovir | 1.59e-04 | 52 | 46 | 3 | CID000003324 | |
| Drug | tridodecyl phosphite | 1.68e-04 | 53 | 46 | 3 | CID000076495 | |
| Drug | AC1L3JHX | 2.15e-04 | 146 | 46 | 4 | CID000090206 | |
| Drug | 3-butene-1,2-diol | 2.17e-04 | 11 | 46 | 2 | CID000010338 | |
| Drug | mercuric bromide | 2.58e-04 | 1076 | 46 | 9 | ctd:C042720 | |
| Drug | 3-aminobenzamide | 2.77e-04 | 156 | 46 | 4 | CID000001645 | |
| Drug | hexadecyl octanoate | 2.82e-04 | 63 | 46 | 3 | CID000448864 | |
| Drug | Tx F | 3.58e-04 | 14 | 46 | 2 | CID006852176 | |
| Drug | BDE-47 | 3.58e-04 | 14 | 46 | 2 | CID000095170 | |
| Drug | phenylethylmalonamide | 4.12e-04 | 15 | 46 | 2 | CID000023611 | |
| Drug | anti-O | 4.53e-04 | 74 | 46 | 3 | CID000017345 | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; PC3; HT_HG-U133A | 4.66e-04 | 179 | 46 | 4 | 4248_UP | |
| Drug | AC1NE2TW | 4.71e-04 | 16 | 46 | 2 | CID004635679 | |
| Drug | feldspar | 4.71e-04 | 16 | 46 | 2 | CID003080680 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 4.76e-04 | 180 | 46 | 4 | 5202_DN | |
| Drug | SAHA; Down 200; 10uM; HL60; HT_HG-U133A | 4.76e-04 | 180 | 46 | 4 | 2680_DN | |
| Drug | Nortriptyline hydrochloride [894-71-3]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 4.96e-04 | 182 | 46 | 4 | 7422_UP | |
| Drug | Primaquine diphosphate [63-45-6]; Up 200; 8.8uM; HL60; HT_HG-U133A | 5.06e-04 | 183 | 46 | 4 | 1343_UP | |
| Drug | azobenzene | 5.33e-04 | 17 | 46 | 2 | CID000002272 | |
| Drug | 0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.38e-04 | 186 | 46 | 4 | 6900_UP | |
| Drug | 3-hydroxy-4-prenyl-5-methoxystilbene-2-carboxylic acid | 5.48e-04 | 79 | 46 | 3 | ctd:C549543 | |
| Drug | Estradiol-17 beta [50-28-2]; Up 200; 14.6uM; HL60; HT_HG-U133A | 5.60e-04 | 188 | 46 | 4 | 1299_UP | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 5.60e-04 | 188 | 46 | 4 | 5224_DN | |
| Drug | Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; HL60; HT_HG-U133A | 5.60e-04 | 188 | 46 | 4 | 3102_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 5.60e-04 | 188 | 46 | 4 | 3177_UP | |
| Drug | retinoic acid; Down 200; 1uM; HL60; HT_HG-U133A | 5.72e-04 | 189 | 46 | 4 | 6170_DN | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.72e-04 | 189 | 46 | 4 | 5675_UP | |
| Drug | Lorglumide sodium salt [97964-56-2]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 5.72e-04 | 189 | 46 | 4 | 5254_DN | |
| Drug | wortmannin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 5.72e-04 | 189 | 46 | 4 | 869_DN | |
| Drug | Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 5.72e-04 | 189 | 46 | 4 | 3165_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; HL60; HT_HG-U133A | 5.95e-04 | 191 | 46 | 4 | 6173_DN | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 5.95e-04 | 191 | 46 | 4 | 6022_DN | |
| Drug | Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A | 5.95e-04 | 191 | 46 | 4 | 5434_DN | |
| Drug | GR 55562 | 5.99e-04 | 18 | 46 | 2 | CID000128017 | |
| Drug | racer | 5.99e-04 | 18 | 46 | 2 | CID000091677 | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 6.06e-04 | 192 | 46 | 4 | 7489_UP | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 6.06e-04 | 192 | 46 | 4 | 2699_DN | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; HL60; HG-U133A | 6.06e-04 | 192 | 46 | 4 | 1589_UP | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A | 6.06e-04 | 192 | 46 | 4 | 3087_UP | |
| Drug | clozapine; Down 200; 10uM; HL60; HT_HG-U133A | 6.06e-04 | 192 | 46 | 4 | 6188_DN | |
| Drug | Syrosingopine [84-36-6]; Up 200; 6uM; MCF7; HT_HG-U133A | 6.06e-04 | 192 | 46 | 4 | 6213_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HG-U133A | 6.06e-04 | 192 | 46 | 4 | 23_UP | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 6.06e-04 | 192 | 46 | 4 | 3400_DN | |
| Drug | Nimodipine [66085-59-4]; Down 200; 9.6uM; HL60; HT_HG-U133A | 6.18e-04 | 193 | 46 | 4 | 3103_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 6.18e-04 | 193 | 46 | 4 | 6223_UP | |
| Drug | STOCK1N-35215; Up 200; 10uM; MCF7; HT_HG-U133A | 6.18e-04 | 193 | 46 | 4 | 6422_UP | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; HL60; HT_HG-U133A | 6.18e-04 | 193 | 46 | 4 | 1341_UP | |
| Drug | Omeprazole [73590-58-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 6.18e-04 | 193 | 46 | 4 | 4951_DN | |
| Drug | Dosulepin hydrochloride [897-15-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 6.18e-04 | 193 | 46 | 4 | 5986_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; HL60; HT_HG-U133A | 6.18e-04 | 193 | 46 | 4 | 1155_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.18e-04 | 193 | 46 | 4 | 5239_DN | |
| Drug | Norcyclobenzaprine [303-50-4]; Down 200; 15.4uM; HL60; HT_HG-U133A | 6.30e-04 | 194 | 46 | 4 | 2469_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; HL60; HT_HG-U133A | 6.30e-04 | 194 | 46 | 4 | 2735_DN | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; PC3; HT_HG-U133A | 6.30e-04 | 194 | 46 | 4 | 5075_DN | |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A | 6.30e-04 | 194 | 46 | 4 | 7283_DN | |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.30e-04 | 194 | 46 | 4 | 3867_DN | |
| Drug | Orphenadrine hydrochloride [341-69-5]; Up 200; 13uM; PC3; HT_HG-U133A | 6.30e-04 | 194 | 46 | 4 | 4537_UP | |
| Drug | (+,-)-Synephrine [94-07-5]; Down 200; 24uM; HL60; HT_HG-U133A | 6.30e-04 | 194 | 46 | 4 | 6156_DN | |
| Drug | Dapsone [80-08-0]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 6.30e-04 | 194 | 46 | 4 | 5498_UP | |
| Drug | Pentylenetetrazole [54-95-5]; Down 200; 29uM; HL60; HG-U133A | 6.30e-04 | 194 | 46 | 4 | 1408_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; PC3; HT_HG-U133A | 6.30e-04 | 194 | 46 | 4 | 4001_DN | |
| Drug | Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; HL60; HT_HG-U133A | 6.30e-04 | 194 | 46 | 4 | 6128_DN | |
| Disease | von Hippel-Lindau disease (is_marker_for) | 2.38e-06 | 2 | 46 | 2 | DOID:14175 (is_marker_for) | |
| Disease | pancreatic cancer (is_marker_for) | 1.89e-05 | 101 | 46 | 4 | DOID:1793 (is_marker_for) | |
| Disease | Acute Myeloid Leukemia, M1 | 4.36e-05 | 125 | 46 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 4.36e-05 | 125 | 46 | 4 | C1879321 | |
| Disease | Liver Diseases, Parasitic | 8.50e-05 | 9 | 46 | 2 | C0023897 | |
| Disease | Hereditary Diffuse Gastric Cancer | 9.16e-05 | 293 | 46 | 5 | C1708349 | |
| Disease | Stomach Neoplasms | 9.77e-05 | 297 | 46 | 5 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 1.02e-04 | 300 | 46 | 5 | C0024623 | |
| Disease | Leukemia, Myelocytic, Acute | 1.54e-04 | 173 | 46 | 4 | C0023467 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 4.00e-04 | 19 | 46 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | Intrahepatic Cholangiocarcinoma | 6.42e-04 | 24 | 46 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 6.42e-04 | 24 | 46 | 2 | C3805278 | |
| Disease | Cholangiocarcinoma | 7.55e-04 | 26 | 46 | 2 | C0206698 | |
| Disease | stimulant use measurement | 8.76e-04 | 28 | 46 | 2 | EFO_0600076 | |
| Disease | suicidal ideation | 9.40e-04 | 29 | 46 | 2 | EFO_0004320 | |
| Disease | peptic ulcer disease | 1.22e-03 | 33 | 46 | 2 | MONDO_0004247 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.34e-03 | 139 | 46 | 3 | DOID:3908 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGNLYMTESTSPWPS | 266 | O95429 | |
| MTESTSPWPSSGSPQ | 271 | O95429 | |
| TPLSSMGGRSNTQWP | 626 | Q99814 | |
| DNSMTWEASFSPPGP | 151 | Q6QNK2 | |
| LPANPSQPITMTDSW | 1221 | P11274 | |
| GMRPSLQPVSDQWPS | 241 | Q8NFD2 | |
| EATSNDPWGPPSSLM | 26 | Q9H201 | |
| QSAPWQERSTMSLPP | 411 | P57764 | |
| SNPGTPINMPWLGST | 2716 | Q9Y485 | |
| MTTTAFPTTQRPWTP | 376 | Q76M96 | |
| NSPIWESGFTMPPSE | 371 | Q92830 | |
| PQDRPSSPGMDSTPW | 6 | Q5HY64 | |
| CAGPGESWSPSPNSM | 21 | Q14296 | |
| QQATPAPAPGQMSTW | 416 | Q92585 | |
| APAPGQMSTWQQTGP | 421 | Q92585 | |
| PVFPTMDTWPTRSAQ | 896 | Q8WXI7 | |
| SRTPGDVSWMTTPPV | 5611 | Q8WXI7 | |
| SRGPGDMSWQSSPSL | 7076 | Q8WXI7 | |
| SRSPGDMLWPSQSSV | 8246 | Q8WXI7 | |
| PTTGSRPTQVWPMTG | 1211 | Q6W4X9 | |
| PMASDPNNSWTSSAP | 1606 | Q8NEZ4 | |
| TPSWANPSPTPVISM | 666 | P19823 | |
| SPWSQLLSSPMETPS | 21 | Q8TDN1 | |
| PSSMWSGQASVNPPL | 661 | O43312 | |
| GSPSQPTSTAVLMPW | 106 | Q9C000 | |
| QSAPPSSPLSPNWMS | 486 | Q6ZU69 | |
| GSMTTPANWNSPLRP | 126 | Q13093 | |
| WDRGSPNLTPSPQPM | 1631 | Q7Z442 | |
| MGTPWTESRSPPAEN | 311 | P08887 | |
| PMQGRTTPSPEDSSW | 436 | P16070 | |
| ANPSSSSRWIPLQPM | 26 | Q7Z3S7 | |
| AQPAMTPASASPSWG | 101 | Q674R7 | |
| AWVTGNATTPPMPEQ | 806 | Q14767 | |
| TWPPRPVTSMNDTLF | 336 | Q9Y4J8 | |
| PTPMASQGPQAWDVT | 71 | Q8NFL0 | |
| TNECQGTMWAPTSPP | 16 | Q9Y238 | |
| PSGTSVPFWVRMSPE | 41 | Q14773 | |
| NPEPTGYNWSTTMGP | 271 | P15151 | |
| SPSMPSLNQTWPELN | 401 | Q96D71 | |
| PPSNFTGSSPWMEIS | 291 | Q5JWF2 | |
| NSSWLPGSPMPQAQS | 551 | Q8NDX1 | |
| PSLPSTTEGQMWASP | 76 | Q2NL68 | |
| TWPPSTSQADRSPMP | 481 | Q96KW2 | |
| MSCQASGQPPPTIRW | 51 | Q8WZ75 | |
| MPPWPPDSQISSQRS | 976 | Q8WZ75 | |
| GNSASRPTMPSGEWA | 941 | Q15596 | |
| RPTMPSGEWAPQSSA | 946 | Q15596 | |
| MQPSWTPAPVQRTAC | 1 | Q9BRP9 | |
| GMNWSCRTPEPNPVT | 431 | Q9Y572 | |
| LVSGPDWNPNTSQPM | 31 | Q8N9X3 | |
| DWNPNTSQPMPGSPA | 36 | Q8N9X3 | |
| RAPALSSSWQPPANM | 1126 | Q5SXM2 | |
| SSSWQPPANMNREPE | 1131 | Q5SXM2 | |
| AQSGMSQPDPSWPLL | 286 | Q9Y6M0 | |
| PLNSTQWMNDPETGP | 376 | Q9BSL1 | |
| PSLMSTTQSRPPWMN | 356 | Q15637 | |
| TTQSRPPWMNSGPSE | 361 | Q15637 | |
| RPTGNTSWLMSLENP | 1201 | P49815 | |
| MSPTTGPQPNPRAWE | 1 | Q6ZRX8 | |
| AWMNDTASTIPPPAT | 101 | P54219 |